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OBJECTIVEdDAFNE (Dose Adjustment For Normal Eating), a structured education pro-
gram in ﬂexible insulin therapy, has been widely adopted in the U.K. after validation in a ran-
domized trial. To determine beneﬁts in routine practice, we collected biomedical and
psychological data from all participants attending during a 12-month period.
RESEARCH DESIGN AND METHODSdHbA1c, weight, self-reported hypoglycemia
awareness, severe hypoglycemia frequency, PAID (Problem Areas In Diabetes), HADS (Hospital
Anxiety and Depression Scale), and EuroQol Group 5-Dimension Self-Report Questionnaire
scores were recorded prior to DAFNE and after 1 year.
RESULTSdComplete baseline and follow-up HbA1c data were available for 639 (54.9%) of
1,163 attendees. HbA1c fell from 8.51 6 1.41 (mean 6 SD) to 8.24 6 1.29% (difference 0.27
[95% CI 0.16–0.38]; P, 0.001), with a greater mean fall of 0.44% from baseline HbA1c.8.5%.
Severe hypoglycemia rate fell from 1.76 8.5 to 0.66 3.7 episodes per person per year (1.1 [0.7–
1.4]) and hypoglycemia recognition improved in 43% of those reporting unawareness. Baseline
psychological distress was evident, with a PAID score of 25.2 and HADS scores of 5.3 (anxiety)
and 4.8 (depression), falling to 16.7 (8.5 [6.6–10.4]), 4.6 (0.7 [0.4–1.0]), and 4.2 (0.6 [0.3–0.8]),
respectively (all P, 0.001 at 1 year). Clinically relevant anxiety and depression (HADS$8) fell
from 24.4 to 18.0% and 20.9 to 15.5%, respectively.
CONCLUSIONSdA structured education program delivered in routine clinical practice not
only improves HbA1c while reducing severe hypoglycemia rate and restoring hypoglycemia
awareness but also reduces psychological distress and improves perceived well-being.
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S tructured education on ﬂexible in-sulin treatment has been shown toresult in improved glycemic con-
trol, with lower glycated hemoglobin
(HbA1c) and less severe hypoglycemia
3–6 years later (1,2). The U.K.-based
DAFNE (Dose Adjustment For Normal
Eating) program is a 5-day course for
adults with type 1 diabetes, focusing on
adjustment of insulin according to carbo-
hydrate intake and reﬂective use of home
blood glucose monitoring data, derived
from principles pioneered in the success-
ful German language program developed
in Düsseldorf and widely used in Germany
and Austria (1,2). After initial develop-
mental work, the U.K. program was tested
in a three-center randomized controlled
trial (RCT) in which DAFNE training
was associated with clinically relevant im-
provements in HbA1c and in aspects of
quality of life speciﬁc to diabetes (3).
After completion of this trial, DAFNE
has been adapted as part of routine
clinical practice in .60 centers in the
U.K. and the Republic of Ireland. The roll-
out of the program has occurred gradu-
ally, with seven centers starting DAFNE in
2002 and more centers joining each year
since. Expansion has been accompanied
by a quality assurance program, including
collection of participant data on various
biomedical and psychological parameters
in a central audit database prior to course
enrollment and at annual follow-up visits.
To determine whether the beneﬁts of
DAFNE training observed in the trial
setting translate into routine clinical prac-
tice, we have conducted a retrospective
audit of biomedical and psychological
outcomes at baseline (enrollment in the
program) and at 1 year posttraining, in-
cluding all participants who attended
DAFNE courses in one 12-month period.
The primary purpose of the study was to
test the hypothesis that DAFNE education
delivered in routine care would be asso-
ciated with similar improvements in bio-
medical and psychological outcomes to
those seen in the RCT.
RESEARCH DESIGN AND
METHODSdThis study was a retro-
spective audit of data collected prior to
attendance at a DAFNE course and at
follow-up 1 year later. Regulatory ap-
proval for data collection and audit was
obtained from the Newcastle and North
Tyneside Health Authority Joint Ethics
Committee. Demographic and biomedi-
cal data collected comprised age, sex, du-
ration of diabetes, height, weight, blood
pressure, HbA1c, serum creatinine, and
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lipid proﬁle. Self-reported frequency of
severe hypoglycemia was recorded based
on the number of times an individual had
required assistance from another person
to treat hypoglycemia as a result of inca-
pacity in the year before attendance at a
DAFNE course. In addition, subjects
were asked to rate their perceived aware-
ness of hypoglycemia by stating whether
they usually recognized that they were
hypoglycemic at a blood glucose concen-
tration $3 mmol/L, ,3 mmol/L, or not
at all.
Psychological assessment included
three well-validated measures of psycho-
logical well-being relevant to diabetes: the
EuroQol Group 5-Dimension Self-Report
Questionnaire (EQ-5D), a generic mea-
sure of quality of life (4); the Hospital
Anxiety and Depression Scale (HADS), a
screening tool for evidence of anxiety and
depression (5); and Problem Areas In Di-
abetes (PAID), a speciﬁc measure devel-
oped to evaluate the impact of diabetes on
psychological well-being (6). Scores .8
on HADS and $40 for PAID were used
to deﬁne clinically relevant psychological
distress. EQ-5D health states were deter-
mined using an algorithm based on the
U.K. population.
For this study, baseline data were
extracted for all participants attending
DAFNE courses during a 12-month pe-
riod (from 1 January to 31 December
2005), together with linked follow-up
data obtained between 300 and 420 days
postattendance at DAFNE. Data from all
centers participating in DAFNE were
pooled for analysis. Statistical compari-
sons between baseline and follow-up data
were made using a population-averaged
linear model with robust SEs and ex-
changeable correlation structure to allow
for clustering by center for biochemical and
physical parameters and psychological
measures. A negative binomial model
with a coefﬁcient for before versus after
DAFNE with a population-averaged ex-
changeable correlation and robust SEs to
allow for clustering on center were used
for hypoglycemia data. To avoid error due
to regression to the mean, the change in
HbA1c percentage was regressed on the
mean of the HbA1c percentage on the
two occasions (7). All data are presented
as mean and SD or range.
RESULTS
Demographics and data quality
In the audit year, 31 DAFNE centers were
active and 1,163 individuals attended
courses. Complete baseline and follow-
up HbA1c data were available for 639
(54.9%) subjects at 29 centers. The mean
interval between baseline and follow-up
was 3806 62 days. Compared with those
with follow-up data, those with only base-
line data available were younger (mean age
38.8 6 12.8 vs. 41.5 6 13.7 years) with
shorter duration of diabetes (15.86 12 vs.
18.0 6 12.1 years) and higher mean
HbA1c (8.7 6 1.6 vs. 8.5 6 1.4%).
There was a wide distribution in
baseline HbA1c within the cohort (range
5.2–15.3%, lower quartile 7.6%, upper
quartile 9.3%) with 21.0% of subjects
having a baseline HbA1c of ,7.5%, the
cutoff used for exclusion from the original
DAFNE RCT.
Changes in HbA1c, lipids, weight,
and blood pressure
Data on changes in biomedical parame-
ters for the 639 subjects with follow-up
data are shown in Table 1. Over the
course of the year post-DAFNE, mean
HbA1c fell by 0.27% (95% CI 0.17–
0.38; P, 0.001), with no accompanying
changes in weight, blood pressure, or
lipid proﬁle. The regression slope of the
mean pre- and post-DAFNE HbA1c plot-
ted against the difference (post- minus
pre-DAFNE) was 0.092% (P = 0.015),
indicating a greater fall in HbA1c for those
with higher mean HbA1c, with mean fall
in HbA1c of 0.44% for those with baseline
HbA1c .8.5%.
Frequency of severe hypoglycemia
Baseline and follow-up data on hypogly-
cemia frequency were available for 501
subjects. Of these, 125 (25%) had suf-
fered at least one severe hypoglycemic
event in the year preceding DAFNE, with
80 (16%) having had more than one
episode during the preceding year. After
DAFNE, 62% of those who had experi-
enced severe hypoglycemia remained free
of further episodes at follow-up, while
10% of those who had been free of severe
hypoglycemia in the preceding year ex-
perienced one or more episodes. The over-
all mean severe hypoglycemia rate for
the cohort fell from 1.93 (range 0–99) to
0.61 (0–70) episodes/person/year after
DAFNE (difference 1.15 [95% CI 0.73–
1.57]; P , 0.001).
Changes in self-reported
hypoglycemia awareness
For the purposes of this analysis, those
reporting symptom onset ,3 mmol/L or
not at all were considered to have im-
paired awareness of hypoglycemia, and
those recognizing hypoglycemia symp-
toms at a glucose of$3mmol/L were con-
sidered hypoglycemia aware. Baseline
data from this question were available
for 539 subjects, of whom 324 (60%)
were hypoglycemia aware and 215 (40%)
had impaired awareness. Frequency of se-
vere hypoglycemia in the year preced-
ing DAFNE was more than threefold
higher among subjects reporting impaired
awareness (Table 2).
At follow-up, 43% of those with im-
paired awareness at enrollment reported
restoration of the ability to detect hypogly-
cemia at a blood glucose.3 mmol/L. The
rate of severe hypoglycemia fell signiﬁ-
cantly in both groups (Table 2).
Psychological data
Complete pre- and postcourse psycho-
logical data were available for 459 sub-
jects (EQ-5D), 484 subjects (PAID), and
484 subjects (HADS). Mean baseline and
follow-up data derived from these mea-
sures are presented in Table 3. At base-
line, the majority of subjects showed no
impairment in any of the domains of the
Table 1dBiochemical and physical parameters pre- and post-DAFNE
Parameter
Pre-DAFNE 1 year post-DAFNE
Mean SD Mean SD
HbA1c (%) 8.51 1.41 8.24* 1.29
Serum creatinine (mol/L) 80.3 20.1 82.2 22.8
Total cholesterol (mmol/L) 4.7 0.9 4.7 2.0
Triglyceride (mmol/L) 1.1 0.8 1.1 1.3
HDL cholesterol (mmol/L) 1.6 0.5 1.7 0.5
Weight (kg) 75.1 13.8 75.1 14.4
Systolic blood pressure (mmHg) 129 17.2 129 16.6
Diastolic blood pressure (mmHg) 75 9.7 75 9.9
*P , 0.001 for comparison of pre- and post-DAFNE mean values. There were no signiﬁcant differences
between pre- and post-DAFNE means for other parameters.
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EQ-5D, and no changes were observed
during follow-up. However, there was a
small but statistically signiﬁcant improve-
ment in subjects’ overall well-being as
rated on the visual analog scale (VAS) el-
ement of the EQ-5D.
The cohort did demonstrate a high
prevalence of baseline psychological dis-
tress as indicated by the HADS and PAID
results. For the former, 24.4 (anxiety) and
20.5% (depression) of subjects scored
$8, and 21.2% of subjects scored $40
on the PAID questionnaire.
At follow-up, there were statistically
signiﬁcant falls in the mean scores for all
three of these measures (Table 3). In ad-
dition, there were falls in the prevalence of
scores of $8 on both HADS component
scales (for anxiety, from 24.4 to 18.0%;
for depression, from 20.5 to 15.5%) and
a fall in the prevalence of subjects with
PAID scores of$40 (from 20.5 to 9.9%).
CONCLUSIONSdThe U.K. DAFNE
program was initiated in response to the
success of an earlier program developed
in Düsseldorf (1,2). This program was as-
sociated with a prolonged improvement
in mean blood glucose control, as exem-
pliﬁed by reduction in HbA1c concentra-
tion and a fall in severe hypoglycemia rate
(8,9). In1999,with thehelpof theDüsseldorf
team, the program materials were translated
into English (including replacement of
some food images with pictures of foods
more relevant to British culture), and the
U.K. program was tested in an RCT set-
ting. After the success of this trial (3), the
DAFNE program has been widely adopted
for the management of type 1 diabetes in
the U.K. However, those now being en-
rolled into the program represent a broader
demographic group than those who were
included in the original study. Although
subjects with an HbA1c ,7.5% were ex-
cluded from the RCT, 21% of this audit
cohort had HbA1c #7.5% and 25% had
experienced severe hypoglycemia, with
16% having experienced recurrent
episodes.
The high prevalence of subjects with
HbA1c close to target in the present cohort
suggests that improving glycemic control
may not be the main motivation for pa-
tients and health professionals to consider
DAFNE and that other perceived beneﬁts,
including increased lifestyle ﬂexibility,
hypoglycemia avoidance, and the im-
provements in psychological well-being
seen in the original RCT, may be factors
in the decision to participate.
In terms of biomedical outcomes,
these data show that attendance at aDAFNE
course delivered in routine clinical prac-
tice is associated with a small but statisti-
cally signiﬁcant improvement in HbA1c
during a 12-month period, achieved with-
out weight gain. The smaller magnitude of
the change in HbA1c compared with that
achieved in the RCT may reﬂect the high
proportion of individuals enrolled in the
program with initial HbA1c values at or
close to target, with the mean HbA1c of
the cohort being considerably lower than
the mean baseline value of 9.4% reported
for the RCT. Indeed, excluding those
whose HbA1c was ,7.5% from the cur-
rent analysis reveals that the mean fall in
HbA1c for the remainder of the cohort
with follow-up data was 0.46%, which
is close to that seen at 12 months in the
original RCT. The original German pro-
gram reports greater falls in HbA1c, and
we may speculate on the reasons for this
because the DAFNE program tried to be
faithful to the concepts underpinning the
Düsseldorf program. Differences in the
health care culture may contribute, and
it should be noted that DAFNE did not
offer speciﬁc structured follow-up after
the initial training.
In contrast to the DAFNE RCT, this
evaluation demonstrates an association
between DAFNE education and reduc-
tion in self-reported severe hypoglycemia
with perceived improvement in hypogly-
cemia recognition among those who re-
ported inability to detect hypoglycemia at
enrollment. These data are encouraging
and suggest that structured education on
insulin dose adjustment for carbohydrate
intake and exercise can be effective at
preventing hypoglycemia and restoring
hypoglycemia awareness. The documen-
tation of improved hypoglycemia aware-
ness status after participation in a training
program focusing on ﬂexible insulin ther-
apy we believe to be novel. It should be
recognized that a limitation of the data is
that they are based on recollection and self-
reporting of hypoglycemia experience,
with no prospective collection of hypogly-
cemia data during the course of the year.
Nevertheless, it seems clear that participat-
ing in DAFNE both reduces the occurrence
of severe hypoglycemia and helps restore
awareness where this has been lost, despite
the improvement in overall glucose control
that might have been expected to increase
the severe hypoglycemia experience. The
beneﬁts seen may relate to reduced expo-
sure to low blood glucose levels in general
because there are robust data to show that
antecedent hypoglycemia limits the stress
response to subsequent episodes in a re-
versible way (10–12).
In the DAFNE RCT, positive psycho-
logical outcomes of the program were
Table 2dHypoglycemia awareness status and severe hypoglycemia rates at enrollment
and 1 year post-DAFNE
Baseline n
Status at 1 year SH pre-DAFNE SH post-DAFNE
Aware Impaired No data Mean SD Mean SD
Aware 324 202 (62) 81 (25) 41 (13) 0.87 3.99 0.35* 1.63
Impaired
awareness 215 92 (43) 97 (45) 26 (12) 3.6 13.6 1.3* 5.9
All 539 294 (54) 178 (33) 67 (12) 1.7 8.5 0.6* 3.7
Data are n (%) of people in each category at baseline and follow-up, together with self-reported mean number
of severe hypoglycemic (SH) episodes per subject for the year preceding DAFNE attendance and for 1st year
post-DAFNE. *P , 0.05 for comparison of pre- and post-DAFNE mean data.
Table 3dChanges in measures of psychological well-being/distress
Baseline 1 year post-DAFNE
P valueMean SD Mean SD
EQ-5D 0.84 0.16 0.84 0.18 NS
EQ-5D VAS 71.2 20.8 75.1 18.4 0.002
PAID 25.2 17.4 16.7 14.1 ,0.001
HADS (anxiety) 5.3 3.7 4.6 3.5 ,0.001
HADS (depression) 4.8 3.2 4.2 3.1 ,0.001
Mean scores for psychological parameters measured at pre-DAFNE visit and 1 year post-DAFNE, with P value
for comparison of means.
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demonstrated using the Audit of Diabetes-
Dependent Quality of Life (ADDQoL)
questionnaire. For the purpose of auditing
the effects of DAFNE in clinical practice,
this questionnaire was replaced by the use
of one diabetes-speciﬁc measure, PAID,
and two generic measures, HADS and
EQ-5D. These three measures have been
widely used for evaluation of changes in
perceived health status and psychological
distress after an intervention in studies
involving diabetic subjects and are well
validated (13).
As in previous studies, themain EQ-5D
scale shows poor sensitivity for detection
of changes in perceived health status in
diabetes (14). This reﬂects the domain
structure of the questionnaire, with ques-
tions on mobility, ability to self-care, per-
formance of usual activities, pain, and
anxiety or depression, the majority of
which are not relevant to a healthy, ambu-
latory population. However, the EQ-5D
also includes a VAS on which subjects
are asked to rate their perceived health
status, and this did show an improvement
of almost 5% at 1 year post-DAFNE.
HADS comprises two separate scales
designed to identify symptoms of anxiety
and depression in ambulatory subjects
and has been widely used in the study of
mental health status in subjects with
chronic diseases. The original authors of
the scale recommended that a cutoff of 8
on each of the respective scales is consis-
tent with clinically signiﬁcant anxiety and
depression of mild severity, with scores of
$11 indicating moderate severity. The
use of a cutoff value of 8 has been vali-
dated by subsequent work, with a sensi-
tivity and speciﬁcity for identiﬁcation of
clinically relevant anxiety and depression
ranging between 0.7 and 0.9 among pub-
lished studies (15). For the purpose of
this audit, we have used the cutoff of 8
to determine prevalence of mild severity
for both dimensions. On this basis, we
identiﬁed a prevalence of mild to moder-
ate anxiety and depression of 24.4 and
20.5%, respectively, with mean baseline
scores of 5.3 and 4.8. These ﬁgures com-
pare with an overall prevalence of 19.8
and 7.6% respectively reported for a pre-
vious U.K. single-center cohort of 313
type 1 diabetic subjects (16), although a
higher prevalence has been reported in a
further U.K. cohort including both type 1
and type 2 diabetic patients (17). These
data suggest a higher prevalence of sig-
niﬁcant psychological distress among
patients being referred for DAFNE. Be-
cause the program does not speciﬁcally
address psychological issues, the fall in
the prevalence of high scores on these
scales after DAFNE suggests that much
of the measured distress is related to di-
abetes and may be ameliorated by acqui-
sition of new skills after participation in
structured education.
This concept is supported by the
changes seen in mean PAID scores and
in the prevalence of PAID scores $40.
The PAID scale is designed to identify
psychosocial distress speciﬁc to diabetes
and has been validated in both North
American and European populations,
and a cutoff of 40 has been proposed as
deﬁning subjects with signiﬁcant psycho-
logical distress. The mean baseline score
observed in this cohort is very similar to
that reported for a large Dutch type 1 di-
abetic cohort (24.66 18.7), but 1 year after
the structured education, it had fallen to
16.7 + 14.1, a score considerably lower
than anypreviously reported for unselected
type 1 diabetic populations (18).
Taken together, these audit data sug-
gest that the beneﬁts of DAFNE training
observed in the original DAFNE RCT are
obtained in those undergoing DAFNE
training in routine clinical practice, with
signiﬁcant improvements in glycemic
control and psychological distress. In
addition, these data indicate a positive
impact of DAFNE on self-reported fre-
quency of severe hypoglycemia and per-
ceived hypoglycemia awareness.
The use of data collected in routine
clinical practice is both a strength and a
major limitation. Routine data clearly re-
ﬂect the true clinical impact of an educa-
tional intervention when delivered outside
the setting of a clinical trial. However, in
the absence of speciﬁc resources to sup-
port data collection, it is challenging to
collect complete datasets. As a consequence,
data are incomplete, with only 55% ascer-
tainment at follow-up. There is a risk that
the beneﬁcial effects observed may have
been overestimated if a greater proportion
of those who responded less well had
defaulted follow-up and, thus, were not
included in the data collection. However,
review of follow-up rates in centers sug-
gests that the problem was related to the
difﬁculty of collecting audit data in routine
practice rather than default, and it is likely
that most individuals with missing data are
continuing to use DAFNE principles and
attending some follow-up.
In conclusion, the audit data reported
here suggest that the beneﬁts of DAFNE
training observed in the original DAFNE
RCTare obtained in routine clinical practice,
with signiﬁcant improvements in HbA1c
and psychological distress sustained to at
least 1 year. Furthermore, these data indi-
cate additional beneﬁt in reducing rates of
severe hypoglycemia and improving hypo-
glycemia awareness. These ﬁndings, cou-
pled with previously published evidence
conﬁrming its cost-effectiveness, make a
powerful case for routine provision of
high-quality structured education pro-
grams for adults with type 1 diabetes.
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